stockrow
Friday 6 November 2026
Export TECH’s income statement to Excel — free account
Bio-Techne Corp
TECH Healthcare Biotechnology
Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025.
- Revenue
- +1.33%
- EPS
- +418.2%
- Free cash flow
- −6.83%
- Total debt
- −42.2%
Quarter to June 2026, against a year earlier
72.75
0.09
+0.12%
Follow TECH
Alert me
Bio-Techne Corp (TECH) Operating cash flow
Bio-Techne Corp's operating cash flow for fiscal 2026 was $292.1M, unchanged from fiscal 2025. Over the past ten years it has ranged from $139.4M (fiscal 2015) to $352.2M (fiscal 2021); the current reading is higher than 75% of that period. Bio-Techne Corp ranks 17th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $292.1M | 1.57% |
| FY2025 | $287.6M | (3.82%) |
| FY2024 | $299.0M | 17.53% |
| FY2023 | $254.4M | (21.79%) |
| FY2022 | $325.3M | (7.64%) |
| FY2021 | $352.2M | 71.61% |
| FY2020 | $205.2M | 12.99% |
| FY2019 | $181.6M | 6.60% |
| FY2018 | $170.4M | 18.54% |
| FY2017 | $143.7M | (0.30%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $95.4M | 10.10% |
| Mar 2026 | $86.7M | 5.16% |
| Dec 2025 | $82.4M | 198.75% |
| Sep 2025 | $27.6M | (71.91%) |
| 42 more quarters | Free account |
Against its own ten years
Low $139.4M
High $352.2M
Ten-year median
$229.8M
Current reading's percentile
75
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BMRN BioMarin Pharmaceutical Inc. compare | $676.6M |
| TECH Bio-Techne Corp | $292.1M |
| CAI Caris Life Sciences,�Inc. compare | $83.9M |
| TGTX TG Therapeutics, Inc. compare | $17.9M |
| TWST Twist Bioscience Corporation compare | −$53.1M |
| IBRX ImmunityBio, Inc. compare | −$281.1M |
| KYMR Kymera Therapeutics, Inc. compare | −$287.6M |
| SMMT Summit Therapeutics PLC compare | −$458.4M |
| PCVX Vaxcyte, Inc. compare | −$881.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on TECH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement